Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals 
Rising levels of obesity are set to cost the world economy 3.3 percent of GDP by 2060, slowing development in lower-income countries, according to a study published in BMJ Global Health.
The conditions currently cost 2.2 percent of global GDP, and the biggest increases are expected in lower-resourced countries.
In terms of absolute costs, China, the US, and India are expected to bear the brunt of the damage, with costs of $10 trillion, $2.5 trillion, and $850 billion, respectively.
The worst affected nations are anticipated to be Trinidad and Tobago with 10.2 percent of GDP and the United Arab Emirates with 11.0% of GDP being accounted for by obesity.
Both direct costs, namely medical expenses, and indirect costs from early mortality and lost output were examined in the report.
The study offers the first estimate of the economic effects of obesity, a major contributor to other non-communicable diseases like cancer, diabetes, and heart disorders, on a country-by-country basis.
According to lead author Rachel Nugent at a briefing on the margins of the UN General Assembly, nearly two in three adults globally are now living with obesity and project there would be three in four adults by 2060.
